ARTICLE | Company News
Senexis, The Wellcome Trust neurology news
January 21, 2008 8:00 AM UTC
Senexis received a £2.9 million ($5.7 million) award from the Wellcome Trust’s Seeding Drug Discovery initiative to further develop preclinical compounds that inhibit amyloid-induced toxicity and neur...